SEAGEN INC.

(SGEN)
  Rapport
Geschatte realtime Cboe BZX  -  17/05 16:40:47 CEST
145.91 USD   +2.36%
16/05Amerikaanse aandelen beginnen week overwegend lager temidden van de zwakte van de Empire State Manufacturing
MT
16/05WALL STREET : Wall Street verliest stoom
AM
16/05WALL STREET : Verdeeld beeld Wall Street
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SEAGEN INC.
16/05US Stocks Begin Week Mostly Lower Amid Empire State Manufacturing Weakness
16/05US Stocks Begin Week Mostly Lower as First Manufacturing Data for May Turns Negative
16/05Top Midday Gainers
16/05INSIDER SELL : Seagen
16/05SEAGEN INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits..
16/05Seagen's President, CEO Clay Siegall Resigns Amid Investigation
16/05Seagen Announces Resignation of President, Chairman & CEO Clay Siegall
09/05SECTOR UPDATE : Health Care Stocks Declining Ahead of Monday Close
09/05SECTOR UPDATE : Health Care
09/05Seagen's Shares Drop After CEO Clay Siegall Takes Leave of Absence; Roger Dansey Named ..
09/05Top Midday Decliners
09/05Equities Drop Midday as Economic Growth, Inflation Concerns Mount
09/05Seagen CEO Clay Siegall Takes Leave of Absence; Roger Dansey Named Interim CEO
09/05SEAGEN INC. : Change in Directors or Principal Officers (form 8-K)
09/05Seagen President, CEO and Chairman Clay Siegall Takes Leave of Absence
09/05Seagen President, CEO and Chairman Clay Siegall Takes Leave of Absence
09/05Seagen Inc. Announces CEO Changes
28/04SEAGEN : Reports First Quarter 2022 Financial Results - Form 8-K
28/04SEAGEN INC. Management's Discussion and Analysis of Financial Condition and Results of..
28/04Seagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
28/04SEATTLE GENETICS : Q1 Earnings Snapshot
28/04TRANSCRIPT : Seagen Inc., Q1 2022 Earnings Call, Apr 28, 2022
28/04Seagen Q1 Loss Widens, Revenue Rises; Maintains 2022 Revenue Outlook
28/04Earnings Flash (SGEN) SEAGEN Posts Q1 Revenue $426.5M, vs. Street Est of $401.7M
28/04Seagen Reports First Quarter 2022 Financial Results
28/04EARNINGS REACTION HISTORY : Seagen Inc, 50.0% Follow-Through Indicator, 6.1% Sensitive
28/04Seagen to Highlight Data from Expanding Oncology Portfolio at 2022 American Society of ..
25/04Seagen Q1 Results May Bring Improved 2022 Guidance, Oppenheimer Says
20/04Seagen Plans New Manufacturing Facility in Washington to Boost Cancer Drug Production
20/04Seagen Announces Plans to Expand Pacific Northwest Biomanufacturing Capacity to Support..
20/04Seagen Announces Plans to Expand Pacific Northwest Biomanufacturing Capacity to Support..
15/04SEAGEN INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S..
13/04Seagen-Astellas Pharma Treatment for Urothelial Cancer Gets European Commission Nod
13/04European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or..
13/04Astellas Pharma Inc. and Seagen Inc. Announces European Commission Approves PADCEV™..
13/04European Commission Approves Drug for Urothelial Cancer
11/04INSIDER SELL : Seagen
08/04SEAGEN : Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo - Form 8-..
08/04SEAGEN INC. : Other Events, Financial Statements and Exhibits (form 8-K)
08/04Seagen Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo
08/04Seagen to Highlight Preclinical Data for Enfortumab Vedotin and Two Novel Antibody-Drug..
08/04Seagen to Highlight Preclinical Data for Enfortumab Vedotin and Two Novel Antibody-Drug..
08/04Valores destacados al cierre del mercado norteamericano
07/04Seagen to Host Conference Call and Webcast Discussion of First Quarter 2022 Financial R..
16/03GLOBAL MARKETS LIVE : Apple, Tesla, AMC, Alibaba, TencentÖ
16/03All eyes on the Fed
16/03SANOFI : partenariat avec une biotech américaine sur des anticorps contre le cancer
16/03Les valeurs à suivre aujourd'hui à Wall Street Mercredi 16 mars 2022
16/03CANCER : Sanofi s'associe avec Seagen pour développer des conjugués anticorps-médicament
16/03SEAGEN : partenariat avec Sanofi sur des anticorps contre le cancer
16/03SANOFI : accord de collaboration avec Seagen
16/03Sanofi Starts Collaboration With Seagen For Antibody-Drug Conjugates
16/03Seagen Agrees Collaboration With Sanofi to Develop Antibody-Drug Conjugates for Cancer ..
16/03USA-Les valeurs à suivre à Wall Street (actualisé)
11/03SEAGEN INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits..
11/03Seagen Inc. Announces Marc E. Lippman Will Not Stand for Re-Election as Director
10/03INSIDER SELL : Seagen
07/03TRANSCRIPT : Seagen Inc. Presents at 42nd Annual Cowen Health Care Conference, Mar-07-2022..
01/03Seagen to Present at the Cowen 42nd Annual Health Care Conference
28/02Seagen, Astellas Pharma Say European Medicines Agency Committee Confirms Padcev Recomme..
28/02Astellas and Seagen Announce CHMP Confirms Positive Opinion for PADCEV™ (enfortum..
28/02Astellas Pharma Inc. and Seagen Inc. Announce CHMP Confirms Positive Opinion for PADCEV..
24/02Genmab and Seagen Present First Data on Tisotumab Vedotin (TIVDAKģ) in Patients with He..
21/02RemeGen Turns to Profit in 2021 on Launch of Core Autoimmune, Cancer Drugs; Shares Rise..
17/02TRANSCRIPT : Seagen Inc. Presents at 11th SVB Leerink Annual Global Healthcare Conference ..
14/02Astellas and Seagen Announce Initial Results of PADCEVģ (enfortumab vedotin-ejfv) in Pa..
14/02Seagen and Astellas Announce Initial Results of PADCEV (enfortumab vedotin-ejfv) in Pat..
11/02PUMP / DUMP #21 : This week's gainers and losers
11/02PUMP / DUMP #48 : Les Tops & Flops de la semaine
11/02And then came inflation data
11/02ANALYST RECOMMENDATIONS : AstraZeneca, Snap, Standard Chartered, Twitter, Walt Disney...
10/02US Stocks Tumble, 10-Year Yield Crosses 2% as Annual Inflation Surges to 40-Year High
10/02SECTOR UPDATE : Health Care Stocks Dragged Under After Investors Abandon Equities
10/02Top Midday Decliners
10/02SECTOR UPDATE : Health Care Stocks Losing More Ground as Thursday Session Progresses
1  2  3  4  5  6  7  8  9  10Volgende
OfficiŽle publicaties